NAD+ infusions have become increasingly popular for anti-ageing. But are they too good to be true?

Scientists and doctors who study neurological disorders are particularly interested in what the growing levels of NAD + could do for their patients. Charalampos Tzoulis, MD, professor of neurology and neurogenetics at the University Hospital of the University of Bergen and Haukeland in Norway, directs a center that tests new treatments for diseases like Parkinson. After administering megadosis of one of the precursors Nad +, Tzoulis and his team were able to show, among a small sample of Parkinson patients, NAD + levels in the brain, a lasting metabolic response and a clinical improvement “Small But significant ”in symptoms. “And it was certain,” continues Tzoulis, “without side effects”. He has since scored 400 patients in a more extensive follow -up test, with expected results in June. If it works, he adds: “It will be big.” As Tzoulis warns, however, dozens of promising interventions have failed in the past. Neurological disorders, aging in general – are thorny processes to disturb.

Tzoulis is not surprised that those who have no neurodegenerative conditions – from Aniston to Oberg to buy a happier average grocery – are locked in research. “These diseases are associated with aging,” he says. “So people think:” If Nad + can help fight neurodegenerative diseases, could I take it to prevent neurodegenerescence? “” With the characteristic Norwegian franchise, Tzoulis says that scientists do not yet have an answer. If his current trial demonstrates that NAD + is a viable treatment option for Parkinson patients, it will evolve in search if this can help prevent the disease. After that, he will investigate the question of whether the general pop population in Smoothie should benefit from supplementation. However, it is clear about its priorities. He and his team did not enter the Nad + match for the crowd of Goop. “We were not looking at well-being. We didn’t look at wrinkles, ”he said.

The same cannot be said of spas in five -star hotels and members of members who now peddle IV and brand injections, varying between $ 900 (* ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹78,000) and $ 1,300 (₹ * 1.12 Lakh) a session. It’s a shame, according to almost all doctors and researchers I talk to, that they don’t work. “The IV drops are not necessary and do not have much sense, because there is no carrier to integrate the NAD + molecule into the cells,” explains Sagner. When fans boast their wonderful awards, Eric Verdin, president and chief executive officer of the Buck Institute for Research on Aging, suspects that their reactions are due to “a strong placebo effect”. Tzoulisputsit in non -scientific terms: “in simple terms, intramuscular admission and IV Nad + is silly.”